RAPS is closely monitoring developments in the Coronavirus (COVID-19) outbreak. See our public safety page for the latest updates.

 
Regulatory Focus™ > News Articles > Regulatory Update

Regulatory Update

Posted 01 November 2010

In this Issue
  • FDA Issues Draft Guidance for When an IND Is Required
  • Live Biotherapeutic Products Clinical Trial Guidance Available
  • EMA Becomes More Transparent Regarding Document Access and Conflicts of Interest

Regulatory Focus newsletters

All the biggest regulatory news and happenings.

Subscribe